{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:30:41Z","timestamp":1770903041891,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s11894-003-0042-6","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T18:36:55Z","timestamp":1179599815000},"page":"512-517","source":"Crossref","is-referenced-by-count":44,"title":["Extraintestinal complications of inflammatory bowel disease"],"prefix":"10.1007","volume":"5","author":[{"given":"Tim","family":"Orchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"42_CR1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","volume":"40","author":"O Palm","year":"2001","unstructured":"Palm O, Moum B, Jahnsen J, Gran JT: The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 2001, 40:1256\u20131261.","journal-title":"Rheumatology"},{"key":"42_CR2","first-page":"511","volume":"29","author":"O Palm","year":"2002","unstructured":"Palm O, Moum B, Ongre A, Gran JT: Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (The IBSEN study). J Rheumatol 2002, 29:511\u2013515.","journal-title":"J Rheumatol"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0899-7071(95)00046-S","volume":"19","author":"N McEniff","year":"1995","unstructured":"McEniff N, Eustace S, McCarthy C, et al.: Asymptomatic sacroiliitis in inflammatory bowel disease: assessment by computed tomography. Clin Imaging 1995, 19:258\u2013262.","journal-title":"Clin Imaging"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1259\/0007-1285-55-659-821","volume":"55","author":"JE Agnew","year":"1982","unstructured":"Agnew JE, Pocock DG, Jewell DP: Sacroiliac joint uptake ratios in inflammatory bowel disease: relationship to back pain and to activity of bowel disease. Br J Radiol 1982, 55:821\u2013826.","journal-title":"Br J Radiol"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.2.5463.675","volume":"2","author":"V Wright","year":"1965","unstructured":"Wright V, Watkinson G: Sacroiliitis and ulcerative colitis. BMJ 1965, 2:675\u2013680.","journal-title":"BMJ"},{"key":"42_CR6","first-page":"518","volume":"30","author":"S Steer","year":"2003","unstructured":"Steer S, Jones J, Hibbert J, et al.: Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn\u2019s disease. J Rheumatol 2003, 30:518\u2013522.","journal-title":"J Rheumatol"},{"key":"42_CR7","first-page":"W1298","volume":"122","author":"T Orchard","year":"2002","unstructured":"Orchard T, Holt H, Bradley L, et al.: Prevalence of sacroiliitis in Crohn\u2019s disease, and its correlation with clinical, radiologic and genotypic parameters. Gastroenterology 2002, 122:W1298.","journal-title":"Gastroenterology"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8","volume":"44","author":"S Smale","year":"2001","unstructured":"Smale S, Natt RS, Orchard TR, et al.: Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001, 44: 2728\u20132736. An extensive review of the relationship between intestinal inflammation, spondyloarthropathies, and nonsteroidal NSAIDs that explores the interactions.","journal-title":"Arthritis Rheum"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","volume":"170","author":"E May","year":"2003","unstructured":"May E, Dorris ML, Satumtira N, et al.: CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003, 170:1099\u20131105.","journal-title":"J Immunol"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP: Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998, 42:387\u2013391.","journal-title":"Gut"},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","volume":"17","author":"W Reinisch","year":"2003","unstructured":"Reinisch W, Miehsler W, Dejaco C, et al.: An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther 2003, 17:1371\u20131380.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","volume":"97","author":"H Herfarth","year":"2002","unstructured":"Herfarth H, Obermeier F, Andus T, et al.: Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn\u2019s disease. Am J Gastroenterol 2002, 97: 2688\u20132690.","journal-title":"Am J Gastroenterol"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/gast.2002.35396","volume":"123","author":"TR Orchard","year":"2002","unstructured":"Orchard TR, Chua CN, Ahmad T, et al.: Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002, 123:714\u2013718.","journal-title":"Gastroenterology"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard TR, Thiyagaraja S, Welsh KI, et al.: Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000, 118:274\u2013278.","journal-title":"Gastroenterology"},{"key":"42_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/000155501750208128","volume":"81","author":"S Labunski","year":"2001","unstructured":"Labunski S, Posern G, Ludwig S, et al.: Tumour necrosis factoralpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001, 81:18\u201321.","journal-title":"Acta Derm Venereol"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004836-200301000-00005","volume":"36","author":"HH Fidder","year":"2003","unstructured":"Fidder HH, Avidan B, Lahav M, et al.: Clinical and demographic characterization of Jewish Crohn\u2019s disease patients in Israel. J Clin Gastroenterol 2003, 36:8\u201312.","journal-title":"J Clin Gastroenterol"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1526-0968.2003.00002.x","volume":"7","author":"K Fukunaga","year":"2003","unstructured":"Fukunaga K, Sawada K, Fukuda Y, et al.: Extracorporeal monocyte granulocytapheresis was effective for a patient of erythema nodosum concomitant with ulcerative colitis. Therap Apher Dial 2003, 7:122\u2013126.","journal-title":"Therap Apher Dial"},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","volume":"356","author":"F Bosch Van den","year":"2000","unstructured":"Van den Bosch F, Kruithof E, De Vos M, et al.: Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000, 356:1821\u20131822.","journal-title":"Lancet"},{"key":"42_CR19","first-page":"295","volume":"26","author":"G Vanbiervliet","year":"2002","unstructured":"Vanbiervliet G, Anty R, Schneider S, et al.: Sweet\u2019s syndrome and erythema nodosum associated with Crohn\u2019s disease treated by infliximab [in French]. Gastroenterol Clin Biol 2002, 26:295\u2013297.","journal-title":"Gastroenterol Clin Biol"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","volume":"7","author":"S Friedman","year":"2001","unstructured":"Friedman S, Marion JF, Scherl E, et al.: Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001, 7:1\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/095466301750163518","volume":"12","author":"CC Lyon","year":"2001","unstructured":"Lyon CC, Stapleton M, Smith AJ, et al.: Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatol Treat 2001, 12:13\u201317.","journal-title":"J Dermatol Treat"},{"key":"42_CR22","first-page":"49","volume":"15","author":"SM Geren","year":"2003","unstructured":"Geren SM, Kerdel FA, Falabella AF, Kirsner RS: Infliximab: a treatment option for ulcerative pyoderma gangrenosum. Wounds 2003, 15:49\u201353.","journal-title":"Wounds"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000065860","volume":"205","author":"F Grange","year":"2002","unstructured":"Grange F, Djilali-Bouzina FF, Weiss AM, et al.: Corticosteroidresistant pyoderma gangrenosum associated with Crohn\u2019s disease: rapid cure with infliximab. Dermatology 2002, 205: 278\u2013280.","journal-title":"Dermatology"},{"key":"42_CR24","first-page":"258","volume":"13","author":"A Zaccagna","year":"2003","unstructured":"Zaccagna A, Bertone A, Puiatti P, et al.: Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of pyoderma gangrenosum associated with Crohn\u2019s disease. Eur J Dermatol 2003, 13:258\u2013260.","journal-title":"Eur J Dermatol"},{"key":"42_CR25","first-page":"108","volume":"4","author":"L Claridge","year":"2003","unstructured":"Claridge L, Wright M, Travis S: Resolution of pyoderma gangrenosum associated with Crohn\u2019s disease after a single infusion of infliximab. Inflamm Bowel Dis Monitor 2003, 4:108\u2013110.","journal-title":"Inflamm Bowel Dis Monitor"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","volume":"41","author":"RN Maini","year":"1998","unstructured":"Maini RN, Breedveld FC, Kalden JR, et al.: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998, 41:1552\u20131563.","journal-title":"Arthritis Rheum"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00054725-200303000-00004","volume":"9","author":"I Storch","year":"2003","unstructured":"Storch I, Sachar D, Katz S: Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003, 9:104\u2013115. A thorough review of the literature is presented. Although there is little to suggest specific lung conditions related to IBD, nonspecific pulmonary function abnormalities occur.","journal-title":"Inflamm Bowel Dis"},{"key":"42_CR28","first-page":"384","volume":"68","author":"G Haralambou","year":"2001","unstructured":"Haralambou G, Teirstein AS, Gil J, Present DH: Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mount Sinai J Med 2001, 68:384\u2013388.","journal-title":"Mount Sinai J Med"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1572-0241.2002.05473.x","volume":"97","author":"KR Herrlinger","year":"2002","unstructured":"Herrlinger KR, Noftz MK, Dalhoff K, et al.: Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002, 97:377\u2013381.","journal-title":"Am J Gastroenterol"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS: AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003, 124:795\u2013841. Exhaustive review of the literature regarding osteoporosis in IBD up to 2002.","journal-title":"Gastroenterology"},{"key":"42_CR31","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association: Medical position statement: Guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003, 124:791\u2013794. Summary of the AGA position regarding the diagnosis and management of IBD-related osteoporosis.","DOI":"10.1053\/gast.2003.50107"},{"key":"42_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s005350300042","volume":"38","author":"C Tirpitz von","year":"2003","unstructured":"von Tirpitz C, Klaus J, Steinkamp M, et al.: Quantitative ultrasound of the proximal phalanges and dual-energy X-ray absorptiometry in Crohn\u2019s disease patients with osteopenia. J Gastroenterol 2003, 38:238\u2013243.","journal-title":"J Gastroenterol"},{"key":"42_CR33","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1046\/j.1365-2036.2002.01363.x","volume":"16","author":"EJ Lamb","year":"2002","unstructured":"Lamb EJ, Wong T, Smith DJ, et al.: Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002, 16:1895\u20131902.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/003655202753416876","volume":"37","author":"J Jahnsen","year":"2002","unstructured":"Jahnsen J, Falch JA, Mowinckel P, Aadland E: Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:192\u2013199.","journal-title":"Scand J Gastroenterol"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00054725-200203000-00003","volume":"8","author":"A Habtezion","year":"2002","unstructured":"Habtezion A, Silverberg MS, Parkes R, et al.: Risk factors for low bone density in Crohn\u2019s disease. Inflamm Bowel Dis 2002, 8:87\u201392.","journal-title":"Inflamm Bowel Dis"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1023\/A:1024171529000","volume":"48","author":"Jong DJ De","year":"2003","unstructured":"De Jong DJ, Mannaerts L, Van Rossum GM, et al.: Longitudinal study of bone mineral density in patients with Crohn\u2019s disease. Dig Dis Sci 2003, 48:1355\u20131359.","journal-title":"Dig Dis Sci"},{"key":"42_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","volume":"156","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L: Fracture risk in patients with celiac disease, Crohn\u2019s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002, 156:1\u201310.","journal-title":"Am J Epidemiol"},{"key":"42_CR38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/gast.2002.34779","volume":"123","author":"EV Loftus","year":"2002","unstructured":"Loftus EV, Crowson CS, Sandborn WJ, et al.: Long-term fracture risk in patients with Crohn\u2019s disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002, 123: 468\u2013475.","journal-title":"Gastroenterology"},{"key":"42_CR39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","volume":"51","author":"J Klaus","year":"2002","unstructured":"Klaus J, Armbrecht G, Steinkamp M, et al.: High prevalence of osteoporotic vertebral fractures in patients with Crohn\u2019s disease. Gut 2002, 51:654\u2013658.","journal-title":"Gut"},{"key":"42_CR40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2036.2003.01448.x","volume":"17","author":"C Tirpitz von","year":"2003","unstructured":"von Tirpitz C, Klaus J, Steinkamp M, et al.: Therapy of osteoporosis in patients with Crohn\u2019s disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther 2003, 17: 807\u2013816.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1053\/gast.2002.36613","volume":"123","author":"H Izzedine","year":"2002","unstructured":"Izzedine H, Simon J, Piette AM, et al.: Primary chronic interstitial nephritis in Crohn\u2019s disease. Gastroenterology 2002, 123:1436\u20131440.","journal-title":"Gastroenterology"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0272-6386(03)00208-7","volume":"41","author":"AJ Shaer","year":"2003","unstructured":"Shaer AJ, Stewart LR, Cheek DE, et al.: IgA antiglomerular basement membrane nephritis associated with Crohn\u2019s disease: a case report and review of glomerulonephritis in inflammatory bowel disease. Am J Kidney Dis 2003, 41:1097\u20131109.","journal-title":"Am J Kidney Dis"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2796.2003.01082.x","volume":"253","author":"L Hyttinen","year":"2003","unstructured":"Hyttinen L, Kaipiainen-Seppanen O, Halinen M: Recurrent myopericarditis in association with Crohn\u2019s disease. J Intern Med 2003, 253:386\u2013388.","journal-title":"J Intern Med"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10067-002-0679-9","volume":"22","author":"C Christopoulos","year":"2003","unstructured":"Christopoulos C, Savva A, Pylarinou S, et al.: Localised gastrocnemius myositis in Crohn\u2019s disease. Clin Rheumatol 2003, 22:143\u2013145.","journal-title":"Clin Rheumatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-003-0042-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-003-0042-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-003-0042-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:03:46Z","timestamp":1559419426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-003-0042-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s11894-003-0042-6","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}